CURRENT
ISSUE
1622

ALLERGIC RHINITIS

The choice of drugs for treatment of allergic rhinitis depends on the severity of symptoms and whether they are are intermittent or persistent (see Table 1).1

H1-ANTIHISTAMINES — Oral second-generation H1-antihistamines (see Table 2) are recommended for initial treatment of intermittent allergic rhinitis symptoms (nasal itching, sneezing, and rhinorrhea). They can also reduce ocular symptoms (itching, tearing, redness).1

Oral first-generation...  Continue reading

More from Issue 1622
Previous Issue: 1621      April 5, 2021
Coming Soon
Vibegron (Gemtesa) for Overactive Bladder
Fluvoxamine for COVID-19?
Evinacumab (Evkeeza) for Homozygous Familial Hypercholesterolemia
Tirbanibulin (Klisyri) for Actinic Keratosis
Search
Donate
Subscribe
Conversation
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
Advance Release
ADVANCE
RELEASE

The oral fixed-dose combination of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker (ARB) valsartan (Entresto – Novartis) was approved by the FDA in 2015 to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction (HFrEF; LVEF <40%).Continue reading

 Tweets